Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma

Activation of MAP Kinase Signaling Through ERK5 But Not ERK1 Expression Is Associated with Lymph Node Metastases in Oral Squamous Cell Carcinoma (OSCC)

(2015) Carsten Sticht et al.   NEOPLASIA

Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities

(2012) H. J. Jung et al.   BLOOD

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer

(2012) Nathan R West et al.   ENDOCRINE-RELATED CANCER

Genital human papillomavirus infections: current and prospective therapies

(2012) M. A. Stanley   JOURNAL OF GENERAL VIROLOGY

Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: A retrospective study

(2012) Ting Jin et al.   Journal of Translational Medicine

TG2, a novel extracellular protein with multiple functions

(2011) Zhuo Wang et al.   AMINO ACIDS

Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?

(2011) Santosh Kumar et al.   AMINO ACIDS

Extracellular TG2: emerging functions and regulation

(2011) Alexey M. Belkin   FEBS Journal

Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness

(2011) David M Winder et al.   JOURNAL OF PATHOLOGY

Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles

(2011) Balaji Muralidhar et al.   JOURNAL OF PATHOLOGY

Rheumatoid arthritis therapy: Advances from bench to bedside

(2010) Soo-In Choi et al.   AUTOIMMUNITY

Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer

(2010) Kapil Mehta et al.   BIOCHEMICAL PHARMACOLOGY

Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells

(2010) Anupam Kumar et al.   PLoS One

TGM2 Is a Novel Marker for Prognosis and Therapeutic Target in Colorectal Cancer

(2009) Norikatsu Miyoshi et al.   ANNALS OF SURGICAL ONCOLOGY

Fibronectin–integrin mediated signaling in human cervical cancer cells (SiHa)

(2009) Gargi Maity et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor κB expression

(2009) Ruchi Gupta et al.   VIRCHOWS ARCHIV

Quantitative Proteomic Signature of Liver Cancer Cells: Tissue Transglutaminase 2 Could Be a Novel Protein Candidate of Human Hepatocellular Carcinoma

(2008) Yulin Sun et al.   JOURNAL OF PROTEOME RESEARCH

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha

(2008) Luigi Scotto et al.   Molecular Cancer

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

(2008) Da Wei Huang et al.   NUCLEIC ACIDS RESEARCH